Leg blood-flow catheter placed routinely or only when needed during heart support
Compares routine versus as-needed leg catheter placement in people receiving mechanical heart support.
Key facts
- Who runs it
- Samsung Medical Center
- Where
- Changwon, Incheon, and Seoul, South KoreaSee the 6 sites
- Trial code
- Registry title
- Routine Versus Provisional Distal Perfusion Catheter Placement in Patients Undergoing Mechanical Circulatory Support
- Status
- Recruiting
- People taking part
- 500 people, planned
- Started
- 8 Jul 2026
- Expected to end
- 31 Oct 2030
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Distal perfusion catheter insertion
- Record updated
- 23 October 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults in cardiogenic shock who need a mechanical heart support device placed through the femoral artery. It compares routine versus provisional placement of a distal perfusion catheter.
- Age
- 19 years or older
- Sex
- All sexes can join.
- Disease stage
- Cardiogenic shock that needs mechanical circulatory support through the femoral artery.
- Earlier treatment
- No previous femoral-femoral or femoral-popliteal bypass grafting.
Main reasons for not taking part
- Clear signs of acute limb ischemia right after the support device is placed
- Serious blood clotting problem that makes an invasive procedure too risky because of bleeding
- Pregnant women, women who could have children, or women who are breastfeeding
- Limb ischemia that cannot be reversed and needs a procedure or surgery when the device is placed
- Previous limb amputation
The registry criteria, word for word
Show all 11 criteriaShow less
Who can take part
- Patients aged 19 years old
- Cardiogenic shock requiring mechanical circulatory support through femoral artery approach
- Subject who can verbally confirm understandings of risks and benefits of receiving distal perfusion catheter insertion and he/she or his/her legally authorized representative provides written informed consent prior to any study related procedure
- Under the critically-ill clinical circumstance (unclear consciousness of patient), legally authorized representative can provide written informed consent prior to any study related procedure
Who cannot take part
- Irreversible limb ischemia requiring interventional procedures or surgery at the time of MCS insertion
- Previous history if femoral-femoral bypass grafting or femoral-popliteal bypass grafting
- Previous history of limb amputation
- Significant coagulopathy precluding invasive procedure due to high risk of bleeding
- Apparent symptoms and sign of acute limb ischemia immediately after mechanical circulatory support insertion
- Pregnant women, women with potential childbearing, or lactating women
- Unwilling or unable to obtain informed consent from the participant or legally authorized representative
Where in South Korea
- Gyeongsang National University Changwon hospitalChangwon, South KoreaContact: Jong-Hwa Ahn, MD, PhDNot yet recruiting
- Samsung Medical Center Changwon HospitalChangwon, South KoreaContact: Ik-Hyun Park, MD, PhDNot yet recruiting
- Kwandong University Intl. ST. Mary's HospitalIncheon, South KoreaContact: Hyung-Bok Park, MD, PhDNot yet recruiting
- Eunpyeong St. Mary's HospitalSeoul, South KoreaContact: Suk Min Seo, MD, PhDNot yet recruiting
- Korea University Anam HospitalSeoul, South KoreaContact: Yonghoon Shin, MD, PhDNot yet recruiting
- Samsung Medical CenterSeoul, South KoreaContact: Joo Myung Lee, MD, MPH, PhDTaking people
About the trial
What the trial wants to find out
A prospective, multi-center, open label, randomized controlled, superiority trial to compare clinical outcomes between routine distal perfusion catheter (DPC) insertion versus provisional distal perfusion catheter (DPC) insertion in the occurrence of sign or symptom of acute limb ischemia in patients undergoing mechanical circulatory support (MCS) through femoral artery approach.
The 2 groups in the trial
- Routine distal perfusion catheter insertion groupTreatment being tested
In the routine DPC insertion group, DPC insertion will be performed within 1 hour from MCS or from transfer from outside hospital under MCS. Fluoroscopy-guided DPC insertion will be used. In case of fluoroscopy is not available or patient's hemodynamic condition precludes transfer of patient to catheterization laboratory, bed-side ultrasound-guided DPC will be permitted.
Treatment: Distal perfusion catheter insertion
- Provisional distal perfusion catheter insertion groupExisting treatment, for comparison
In the provisional distal perfusion catheter insertion group, DPC insertion will be performed at the time of symptom or sign of limb ischemia. Fluoroscopy-guided DPC insertion will be used. In case of fluoroscopy is not available or patient's hemodynamic condition precludes transfer of patient to catheterization laboratory, bed-side ultrasound-guided DPC will be permitted.
Treatment: Distal perfusion catheter insertion
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorSaves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Routine Versus Provisional Distal Perfusion Catheter Placement in Patients Undergoing Mechanical Circulatory Support
- Plain-language title
- Leg blood-flow catheter placed routinely or only when needed during heart supportGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 13 November 2026.
- Record updated
- 23 October 2026